The potential value of faecal lactoferrin as a screening test in hospitalized patients with diarrhoea

Overview of attention for article published in Internal Medicine Journal, October 2009

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (72nd percentile)
Good Attention Score compared to outputs of the same age and source (66th percentile)

Mentioned by

patent: 7 patents

Readers on

mendeley: 23 Mendeley

So far, Altmetric has seen 7 patents that reference this research output.

Fecal lactoferrin as a biomarker for determining disease severity and for treating…

Grant US-10295536-B2

United States of America

21 May 2019

Clostridium difficile dehydrogenase and toxin as a biomarker for monitoring infection in…

Grant US-10295535-B2

United States of America

21 May 2019

FECAL LACTOFERRIN AS A BIOMARKER FOR DETERMINING DISEASE SEVERITY AND FOR MONITORING…

Application EP-2705154-A4

European Patent Office

12 Nov 2014

FECAL LACTOFERRIN AS A BIOMARKER FOR DETERMINING DISEASE SEVERITY AND FOR TREATING…

Application US-20140219966-A1

United States of America

07 Aug 2014

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity, including 3 additional patents.